|
⚲
|
| Keyboard |
| Stonepine Capital LP
✚
|
|
|---|---|
| CIK # | 0001370042, 0001440771 |
| CIK | Period |
|---|---|
| 0001370042 0001440771 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Verastem Inc | 17.5 | ||
| R&R Acquisition VI Inc | 17.0 | ||
| Oxygen Biotherapeutics Inc | 15.6 | ||
| Evolus Inc | 9.0 | ||
| Camp4 Therapeutics Corp | 6.1 | ||
| Nektar Therapeutics | 6.1 | ||
| Kempharm Inc | 4.5 | ||
| Access Pharmaceuticals Inc | 3.8 | ||
| Corbus Pharmaceuticals Holdings Inc | 3.6 | ||
| Establishment Labs Holdings Inc | 3.2 | ||
| Kazia Therapeutics Ltd | 2.6 | ||
| AN2 Therapeutics Inc | 2.4 | ||
| Alexandria Real Estate Equities Inc | 2.3 | ||
| Acadia Pharmaceuticals Inc | 2.2 | ||
| Sol-Gel Technologies Ltd | 2.2 | ||
| XOMA Ltd /DE/ | 2.2 | ||
| Rosewind Corp | 2.2 | ||
| Curis Inc | 2.0 | ||
| AP Pharma Inc /DE/ | 1.9 | ||
| CytomX Therapeutics Inc | 1.9 | ||
| Xeris Biopharma Holdings Inc | 1.9 | ||
| TELA Bio Inc | 1.6 | ||
| Inhibikase Therapeutics Inc | 1.6 | ||
| Glycomimetics Inc | 1.6 | ||
| Restorbio Inc | 1.5 | ||
| Si-Bone Inc | 1.5 | ||
| Arsanis Inc | 1.4 | ||
| OKYO Pharma Ltd | 1.4 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001370042] | |
| 4 | [0001370042] | |
| SC 13D | [0001370042] | |
| SC 13G | [0001370042] | |
| 13F-HR | [0001440771] | |
| 3 | [0001440771] | |
| 4 | [0001440771] | |
| SC 13G | [0001440771] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Chiasma Inc CHMA
Common Stock
|
2021-08-05 | Disposed to issuer | 6,770,000 | ||
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-12 | Buy | 1,000 | $0.70 | 700 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-11 | Buy | 40 | $0.69 | 28 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-10 | Buy | 5,202 | $0.69 | 3,589 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-09 | Buy | 4,500 | $0.70 | 3,150 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-06 | Buy | 40 | $0.70 | 28 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-12-05 | Buy | 5,160 | $0.70 | 3,612 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-11-22 | Buy | 89,845 | $0.75 | 67,384 |
|
Novelion Therapeutics Inc NVLNF
Common Stock
|
2019-10-11 | Buy | 100,000 | $0.65 | 65,000 |
|
Lpath Inc APEN
Warrant · derivative
|
2019-08-12 | Other | 1 | ||
|
Lpath Inc APEN
6.0% Convertible Debenture due 2024 · derivative
|
2019-08-12 | Buy | $2,775,000.00 | ||
|
Lpath Inc APEN
Common Stock
|
2019-08-12 | Other | 1,000,000 | ||
|
Lpath Inc APEN
Common Stock
|
2018-12-27 | Sell | 250,000 | $3.00 | 750,000 |
|
Lpath Inc APEN
Common Stock
|
2018-12-26 | Sell | 500,000 | $3.00 | 1,500,000 |
|
Lpath Inc APEN
Common Stock
|
2018-11-21 | Buy | 3,230 | $3.61 | 11,660 |
|
Lpath Inc APEN
Common Stock
|
2018-11-19 | Buy | 54,200 | $3.40 | 184,280 |
|
Lpath Inc APEN
Common Stock
|
2018-11-02 | Buy | 300,000 | $5.00 | 1,500,000 |
|
Lpath Inc APEN
Common Stock
|
2018-01-03 | Buy | 6,339 | $5.78 | 36,639 |
|
Lpath Inc APEN
Common Stock
|
2018-01-02 | Buy | 11,343 | $5.73 | 64,995 |
|
Lpath Inc APEN
Common Stock
|
2017-12-29 | Buy | 5,163 | $5.56 | 28,706 |
| showing 20 of 43 most recent transactions | |||||